Status:
COMPLETED
Decentralized Trial in Atrial Fibrillation Patients
Lead Sponsor:
Stanford University
Conditions:
Atrial Fibrillation
Eligibility:
All Genders
55+ years
Phase:
NA
Brief Summary
The purpose of this study is to validate an approach to decentralize, or virtualize, the clinical trial experience for enrolled subjects, through the coordinated use of multiple digital health and tel...
Eligibility Criteria
Inclusion
- Diagnosis of Atrial Fibrillation documented (health record diagnosis or EKG) within the past year and taking an oral anticoagulant (OAC) medication for stroke prevention
- Uses a smart phone daily and is willing to use apps and home devices for the study
- Agreeable to use a Televisit method to conduct all study visits from trial team
Exclusion
- Active angina, stable or unstable, requiring urgent cardiovascular functional risk stratification (stress testing or catheterization) or intervention. Or has congestive heart failure that is not compensated or in which the subject is not euvolemic, as determined by the treating MD
- Individual has a condition the Investigator believes would interfere with his or her ability to provide informed consent, comply with the study protocol, which might confound the interpretation of the study results or put the person at undue risk.
- Does not speak English
Key Trial Info
Start Date :
August 10 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 12 2021
Estimated Enrollment :
102 Patients enrolled
Trial Details
Trial ID
NCT04471623
Start Date
August 10 2020
End Date
March 12 2021
Last Update
March 24 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Stanford
Stanford, California, United States, 94305